Zobrazeno 1 - 9
of 9
pro vyhledávání: '"H M, Blottière"'
Autor:
B, Buecher, M-F, Heymann, A, Lièvre, J-M, Nguyen, K, Wilson, S, Bézieau, J-F, Mosnier, J-P, Galmiche, H M, Blottière
Publikováno v:
Alimentary pharmacologytherapeutics. 18(7)
Cyclo-oxygenase-2 over-expression has been reported in most advanced human colorectal cancers.To assess the prevalence of cyclo-oxygenase-2 over-expression in non-advanced colorectal cancers, to investigate the correlation between cyclo-oxygenase-2 s
Publikováno v:
European journal of biochemistry. 267(21)
Butyrate is a short chain fatty acid (SCFA) produced by bacterial fermentation of dietary fibers in the colon lumen which severely affects the proliferation of colon cancer cells in in vitro experiments. Although butyrate is able to interfere with nu
Publikováno v:
Digestive diseases and sciences. 45(8)
Short-chain fatty acids are the main end products of bacterial fermentation of carbohydrates. Their role on the metabolism and biology of colonocytes is now well characterized. However, the functional consequences of their presence on intestinal smoo
Autor:
A, Bourreille, J P, Segain, D, Raingeard de la Blétière, S, Siavoshian, G, Vallette, J P, Galmiche, H M, Blottière
Publikováno v:
European journal of clinical investigation. 29(1)
Colonic epithelial cells may behave as antigen-presenting cells. Interleukin 10 (IL-10) is known to play a major role in the intestinal immune system; however, it remains to be determined whether human intestinal epithelial cells express IL-10 recept
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::040493b90072836b49e4085678a746c0
http://europepmc.org/abstract/med/8761679
http://europepmc.org/abstract/med/8761679
Publikováno v:
Europe PubMed Central
Cholecystokinin (CCK) is a peptide released after feeding. Until now, CCK gene expression has been studied only on sacrified animals on mucosa scrapped off the duodenum. OBJECTIVE--The aim of this study was to assess CCK-mRNA detection on duodenal bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2f081905f197efc58c48dcfe23897ec0
http://europepmc.org/abstract/med/8522112
http://europepmc.org/abstract/med/8522112
Publikováno v:
Europe PubMed Central
In our institution, over 200 patients with gastro-intestinal tract carcinomas have been treated with monoclonal antibodies (MAbs) including CO 17-1A. In one clinical trial, MAbs were administered in combination with gamma interferon. Natural killer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6c93fe8bb502975601db8c63e6b28c46
http://europepmc.org/abstract/med/1908336
http://europepmc.org/abstract/med/1908336
Publikováno v:
Europe PubMed Central
The immune response against murine IgG2a immunoglobulin was studied in 42 gastrointestinal cancer patients treated with mouse monoclonal antibodies. IgM, IgA, and all 4 IgG subclasses directed against mouse immunoglobulin were studied. Thirty of 42 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6529380b7fbc0a2363555d43f1d4a8b
http://europepmc.org/abstract/med/2297720
http://europepmc.org/abstract/med/2297720
Publikováno v:
Europe PubMed Central
Ten patients with metastatic adenocarcinomas of the colon or pancreas were treated with multiple injections of monoclonal antibody 17.1A. For each injection, antibody concentration in the patients' sera plateaued during the entire treatment course, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::87edf274d85bdd156ed01b1ae9c13927
http://europepmc.org/abstract/med/3621210
http://europepmc.org/abstract/med/3621210